The global single-use bioprocessing market is experiencing explosive growth, projected to skyrocket from $8.2 billion in 2021 to $20.8 billion by 2026 at an impressive 20.5% compound annual growth rate (CAGR). This surge is fueled by the increasing demand for biopharmaceuticals, driven by an aging global population more susceptible to chronic conditions.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297

Single-use bioprocessing systems offer numerous advantages over traditional stainless-steel equipment, including greater energy efficiency, reduced water usage, smaller footprints, lower costs, quicker implementation, and diminished risk of cross-contamination. While concerns exist around extractables, leachables, and waste disposal, emerging markets in Asia like China and India present lucrative opportunities for this technology.

Major players like Sartorius, Danaher’s Cytiva, Thermo Fisher, and Merck are making massive investments to expand single-use bioprocessing capabilities and meet soaring demand for biologics and vaccines. Thermo Fisher alone invested over $475 million in 2020 to bolster its St. Louis facilities.

The single-use media bags and containers segment currently dominates the market, driven by their widespread use across biomanufacturing processes. However, demand is strong across all application areas including filtration, storage, cell culture, mixing, and purification.

As biopharmaceutical production continues ramping up globally, the future looks extremely bright for flexible, cost-effective single-use bioprocessing solutions to unlock new manufacturing efficiencies and accelerate delivery of life-saving treatments.